Keywords: market, opens, dxs, pcr, patents, expire, manchester

Market opens for DxS as PCR patents expire

Article | 18 April 2005

Print This

Manchester, UK-based pharmacogenomics firm DxS said it expects to see a significant increase in demand for its Scorpions real-time polymerase ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in